Liver Specimen Reference Sets
| Organ | Protocol ID | Reference set title | Cases | Controls | Total participants | Participant groups | Specimen type | Number of specimens | Volume range (mL) | Specimens at NCI-F? | Sequential samples? | Follow-up data? | Pathology | Image files avail? | Incident cancer? |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liver | Hepatocellular carcinoma Early Detection Strategy study (HEDS) |
124 | 1599 | 1723 | N/A | Serum | 49,117 | 0.100–5.0 | ✓ | ✓ | ✓ | | | | |
| | |
|
| | | N/A | Plasma | 50,236 | 0.011–5.0 | | | | | | |
| | |
|
| | | N/A | DNA | 1,398 | 0.01–0.05 | | | | | | |
| Liver | 50 | 50 | 100 | | Serum | 1,329 | 0.01–0.5 | ✓ | | | | | ✓ | ||
| | |
|
| | | | Plasma | 731 | 0.2–0.5 | | | | | | |
| Liver | 111 |
427 | 432 | 871 | | Serum | 10,815 | 0.01–1.0 | ✓ | | | | | | |
| | |
|
| | | | Plasma | 5,090 | 0.2–0.5 | | | | | | |
| Liver | 69 | 71 | 140 | N/A | Plasma | 234 | 0.25-1 | ✓ | | | | | | ||
| | |
|
69 | 71 | 140 | N/A | Serum | 177 | 0.25-1 | ✓ | | | | | |
| | |
|
786 | 1339 Control and 11 unknown | 2136 | N/A | Plasma | TBD | TBD | | | | | | |
| | |
|
786 | 1339 Control and 11 unknown | 2136 | N/A | Serum | TBD | TBD | | | | | | |
| Liver | |
18 | 119 | 137 | N/A | Plasma | 322 | 0.5-2 | ✓ | ✓ | | | | | |
| | |
|
18 | 119 | 137 | N/A | Serum | 253 | 0.5-2 | ✓ | ✓ | | | | |
| | |
|
50 | 1509 | 1559 | N/A | Plasma | TBD | TBD | | ✓ | | | | |
| | |
|
50 | 1509 | 1559 | N/A | Serum | TBD | TBD | | ✓ | | | | |
| Liver | TBD | TBD | Expect 450 | N/A | Serum | TBD | TBD | ✓ | ✓ | ✓ | N/A | ✓ | TBD | ||
| | |
|
| | Expect 450 | N/A | Plasma | TBD | TBD | ✓ | ✓ | ✓ | N/A | ✓ | TBD |
| Liver | TBD | TBD | Expect 450 | N/A | Serum | TBD | 0.25mL-1mL | ✓ | ✓ | ✓ | N/A | ✓ | TBD | ||
| | |
|
| | Expect 450 | | Plasma | TBD | 0.25mL-1mL | ✓ | ✓ | ✓ | N/A | ✓ | TBD |